I speak with infusion leaders every day—from major health systems to independent infusion practices—and the same challenge comes up time and again: speed and efficiency with the intake and prior ...

There were 11 hypersensitivity reactions, all in patients receiving nivolumab. Reducing the infusion time for nivolumab and pembrolizumab to 10 minutes is feasible and safe, according to researchers.